Moreover, clinical studies in thyroid cancer, gastrointestinal stromal tumors, and T cell non-Hodgkin's lymphoma/leukemias suggested that CD26 expression was associated with distant metastasis, recurrence after resection, or poor survival [29]–[31]. This evidence concerns the gene DPP4 and T-cell non-Hodgkin lymphoma.